More dates

    Emerging Technologies for Gut Health


    This event has passed Get tickets

    Event description

    Join the next Australia-New Zealand BioBridge workshop to explore new innovative technologies that are reshaping gastroenterology beyond traditional care settings. From advances in microbiome research, artificial intelligence, virtual reality, wearable technologies, and advanced endoscopy, our expert panel from across the Tasman will explore diverse applications for more personalised care and better patient outcomes. Our speakers include:

    Atmo Biosciences
    The Atmo® Gas Capsule a world-first ingestible gas-sensing capsule to provide unique insights into gut health and microbiome function.The gas-sensing capsule assesses the functional health of a patient’s entire gastrointestinal system and aims to provide: better diagnosis, more targeted and personalized treatment, earlier relief of symptoms and improved healthcare outcomes.The capsule can electronically report important data by continuously detecting gases and wirelessly transmitting the data to provide insights into the location of the capsule, microbiome function and gastrointestinal health.The ingestible capsule offers a potential diagnostic tool for many disorders of the gut from motility disorders, IBS and IBD to liver disease.

    Dr Jerry Zhou, Western Sydney University. Innovating Gut Health through Research, Advocacy, and Commercialisation.
    Dr Zhou's presentation will go over their lab's holistic model to gut health research, through establishing clinical and advocacy partnerships. Dr Zhou will talk about how this has led to several industry-led trials and an example of commercialisation of their very own medical device.Dr Zhou is a senior lecturer and clinical research fellow at the Translational Gastroenterology Laboratory in School of Medicine, Western Sydney University (WSU). He has an emerging international reputation in the fields of gastrointestinal health, medical device development, and clinical trials. Dr Zhou was awarded a PhD in 2014 from the University of Sydney before joining and leading clinical research at the Translational Gastroenterology Laboratory at WSU for 7 years. Over this time, he has produced over 40 publications (80% Q1) and been awarded close to $1M (AUD) in government and industry funding. Dr Zhou has developed active collaborations within national and international institutions, including University of Edinburgh (UK), University of Auckland (NZ), John Hunter Hospital (AUS), and Royal Prince Alfred Hospital (AUS). Dr Zhou has extensive experience working in different facets of the Australian healthcare landscape; serving as a clinical fellow at GI Motility Clinics at Blacktown and Camden Hospitals, roles within advocacy groups, industry partnerships, and founded GutTech company Amazing Gut.

    Alimetry 
    A revolutionary diagnostic solution to assess patients with chronic gastric symptoms. Alimetry's primary product, Gastric Alimetry, is an innovative medical device to help diagnose gastric disorders. The test is indicated in the routine testing of patients with chronic gastric symptoms, including nausea and vomiting, dyspepsia, and upper abdominal pain. It is wearable and non-invasive, using advanced flexible electronics to sense the movements of the stomach from the skin surface. Patients simultaneously log their symptoms into the gastric Alimetry App, resulting in a report which helps to define the correct management strategy for individual patients.

    Associate Professor Peng Du, University of Auckland. 
    Associate Professor Du specialises in the applications of computational physiology, instrumentation, and experimental physiology in the gastrointestinal tract. Based at the Auckland Bioengineering Institute, Associate Professor Du's research interests involve flexible electronics that enabled the first intra-operative high-resolution recording of human gastrointestinal bioelectrical events. In addition, he leads the Virtual Gut mathematical modelling initiative for the development of in-silico multi-scale investigations of digestive functions. 


    Powered by

    Tickets for good, not greed Humanitix dedicates 100% of profits from booking fees to charity